INS and Hyperglycemia: Remarkably, systemic bi-shRNAmousePDX-1 and shRNAmousePDX-1 lipoplexes result in temporal hyperglycemia, representing a predictable off-target effect on mouse islets, since PDX-1 is the predominant regulator of insulin expression.